SCHEMBL105486

Kakonein is a lipid of Polyketides (PK) class. Kakonein is associated with abnormalities such as Fatty Liver, Chronic liver disease, Morphologically altered structure, Hypertensive disease and Cardiovascular Diseases. The involved functions are known as protein expression, Extravasation, Liver damage, mRNA Expression and cell activation. Kakonein often locates in Body tissue, Hepatic, Microvilli, Cytoplasm and Membrane. The associated genes with Kakonein are TJP1 gene, CD14 gene, iberiotoxin, AT-Rich Interactive Domain-Containing Protein 1A and NKS1 gene. The related lipids are dehydrosoyasaponin I and Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of SCHEMBL105486, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with SCHEMBL105486?

SCHEMBL105486 is suspected in Chronic liver disease, Hypertensive disease, Cardiovascular Diseases, Myocardial Infarction, Cerebrovascular accident, Fatty Liver and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with SCHEMBL105486

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Lead Poisoning D007855 4 associated lipids
Adenocarcinoma D000230 166 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Fatty Liver D005234 48 associated lipids
Per page 10 20 50 | Total 43

PubChem Associated disorders and diseases

What pathways are associated with SCHEMBL105486

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with SCHEMBL105486?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with SCHEMBL105486?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with SCHEMBL105486?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with SCHEMBL105486?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with SCHEMBL105486?

Knock-out

Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with SCHEMBL105486

Download all related citations
Per page 10 20 50 100 | Total 919
Authors Title Published Journal PubMed Link
pmid:
Zhao YZ et al. Using PG-Liposome-Based System to Enhance Puerarin Liver-Targeted Therapy for Alcohol-Induced Liver Disease. 2016 AAPS PharmSciTech pmid:26753818
Cheng G et al. Preparation and In Vitro/In Vivo Evaluation of Puerarin Solid Self-Microemulsifying Drug Delivery System by Spherical Crystallization Technique. 2016 AAPS PharmSciTech pmid:26694058
Yue PF et al. The study on the entrapment efficiency and in vitro release of puerarin submicron emulsion. 2009 AAPS PharmSciTech pmid:19381837
Chen AZ et al. Microencapsulation of puerarin nanoparticles by poly(l-lactide) in a supercritical CO(2) process. 2009 Acta Biomater pmid:19463980
Xu J et al. Cyclodextrin-containing hydrogels for contact lenses as a platform for drug incorporation and release. 2010 Acta Biomater pmid:19619677
Zhang CP et al. Genistein-3'-sulfonic acid dihydrate. 2009 Acta Crystallogr Sect E Struct Rep Online pmid:21583946
Zhang GQ et al. Puerarin blocks Na+ current in rat ventricular myocytes. 2003 Acta Pharmacol. Sin. pmid:14653946
Mao CP and Gu ZL Puerarin reduces increased c-fos, c-jun, and type IV collagen expression caused by high glucose in glomerular mesangial cells. 2005 Acta Pharmacol. Sin. pmid:16038632
Su HF et al. Absorptive interactions of concurrent oral administration of (+)-catechin and puerarin in rats and the underlying mechanisms. 2016 Acta Pharmacol. Sin. pmid:26972494
Zhu JH et al. Effects of puerarin on number and activity of endothelial progenitor cells from peripheral blood. 2004 Acta Pharmacol. Sin. pmid:15301738
Qu Q et al. Inhibitory effects of phytochemicals on metabolic capabilities of CYP2D6(*)1 and CYP2D6(*)10 using cell-based models in vitro. 2014 Acta Pharmacol. Sin. pmid:24786236
Chen G et al. Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways. 2014 Acta Pharmacol. Sin. pmid:24608673
Xu XH and Zhao TQ Effects of puerarin on D-galactose-induced memory deficits in mice. 2002 Acta Pharmacol. Sin. pmid:12100749
Zhang GQ et al. Puerarin blocks transient outward K+ current and delayed rectifier K+ current in mice hippocampal CA1 neurons. 2001 Acta Pharmacol. Sin. pmid:11742573
Chauhan NS et al. Spectrofluorimetric estimation of puerarin in Pueraria tuberosa. 2011 May-Jun Acta Pol Pharm pmid:21648202
Lin RC et al. Isoflavonoid compounds extracted from Pueraria lobata suppress alcohol preference in a pharmacogenetic rat model of alcoholism. 1996 Alcohol. Clin. Exp. Res. pmid:8800381
Overstreet DH et al. Suppression of alcohol intake after administration of the Chinese herbal medicine, NPI-028, and its derivatives. 1996 Alcohol. Clin. Exp. Res. pmid:8730211
Overstreet DH et al. Herbal remedies for alcoholism: promises and possible pitfalls. 2003 Alcohol. Clin. Exp. Res. pmid:12605067
Bae HS et al. Hepatoprotective activity of reduohanxiao-tang (yuldahanso-tang) is related to the inhibition of beta-glucuronidase. 2003 Am. J. Chin. Med. pmid:12723760
Liu R et al. Pharmacokinetics of puerarin and ginsenoside Rg1 of CBN injection and the relation with platelet aggregation in rats. 2006 Am. J. Chin. Med. pmid:17163592
Zheng P et al. Therapeutic effect of puerarin on non-alcoholic rat fatty liver by improving leptin signal transduction through JAK2/STAT3 pathways. 2009 Am. J. Chin. Med. pmid:19222113
Zhao M et al. Protective effect of puerarin on acute alcoholic liver injury. 2010 Am. J. Chin. Med. pmid:20387222
Hsiang SW et al. Puerarin accelerates peripheral nerve regeneration. 2011 Am. J. Chin. Med. pmid:22083991
Lu Q et al. Puerarin attenuates calcification of vascular smooth muscle cells. 2014 Am. J. Chin. Med. pmid:24707866
Tan C et al. Puerarin Improves Vascular Insulin Resistance and Cardiovascular Remodeling in Salt-Sensitive Hypertension. 2017 Am. J. Chin. Med. pmid:28830209
Lin RC and Li TK Effects of isoflavones on alcohol pharmacokinetics and alcohol-drinking behavior in rats. 1998 Am. J. Clin. Nutr. pmid:9848526
Wang J et al. Detection of flavonoids and assay for their antioxidant activity based on enlargement of gold nanoparticles. 2007 Anal Bioanal Chem pmid:17479255
Baranowska I and Magiera S Analysis of isoflavones and flavonoids in human urine by UHPLC. 2011 Anal Bioanal Chem pmid:20936271
Tian J and Qin W Quick and sensitive determination of flavonoids by capillary electrophoresis-potential gradient detection. 2009 Anal Sci pmid:19745540
Zeng A et al. Simultaneous analysis and retention behavior of major isoflavonoids in Radix Puerariae lobatae and Radix Puerariae thomsonii by high performance liquid chromatography with cyclodextrins as a mobile phase modifier. 2012 Anal. Chim. Acta pmid:22177078
Luo J et al. Molecularly imprinted layer-coated monodisperse spherical silica microparticles toward affinity-enrichment of isoflavonoid glycosides from Radix puerariae. 2012 Analyst pmid:22553769
Chauhan SK et al. Determination of puerarin from pueraria tuberosa dc by HPLC. 2004 Anc Sci Life pmid:22557128
Zhang WG et al. Puerarin Induces Hepatocellular Carcinoma Cell Apoptosis Modulated by MAPK Signaling Pathways in a Dose-dependent Manner. 2017 Anticancer Res. pmid:28739736
Romero MR et al. Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system. 2005 Antiviral Res. pmid:16122816
Yang L and Tan T An enhanced adsorption in puerarin retention on oligo-beta-cyclodextrin grafted poly(glycidyl methacrylate) media. 2010 Appl. Biochem. Biotechnol. pmid:19067245
Jiang JR et al. Conversion of puerarin into its 7-O-glycoside derivatives by Microbacterium oxydans (CGMCC 1788) to improve its water solubility and pharmacokinetic properties. 2008 Appl. Microbiol. Biotechnol. pmid:18795283
Yu C et al. Permeabilization of Microbacterium oxylans shifts the conversion of puerarin from puerarin-7-O-glucoside to puerarin-7-O-fructoside. 2010 Appl. Microbiol. Biotechnol. pmid:19943046
Kim JM et al. Constituents of the roots of Pueraria lobata inhibit formation of advanced glycation end products (AGEs). 2006 Arch. Pharm. Res. pmid:17121174
Kim SJ et al. Peroxyl radical scavenging capacity of extracts and isolated components from selected medicinal plants. 2010 Arch. Pharm. Res. pmid:20607491
Kim YS et al. The role of intestinal microflora on daidzein excretion in urine in humans treated with Chungpesagantang. 2007 Arch. Pharm. Res. pmid:17489365
Zheng J et al. The effects of puerarin on CYP2D6 and CYP1A2 activities in vivo. 2010 Arch. Pharm. Res. pmid:20195825
Jin SE et al. Anti-inflammatory and antioxidant activities of constituents isolated from Pueraria lobata roots. 2012 Arch. Pharm. Res. pmid:22644850
Hwang YP et al. Protective effects of puerarin on carbon tetrachloride-induced hepatotoxicity. 2007 Arch. Pharm. Res. pmid:18038910
Lee DS et al. Fecal metabolic activities of herbal components to bioactive compounds. 2002 Arch. Pharm. Res. pmid:12009030
Luo CF et al. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for puerarin metabolism in human liver microsomes. 2012 Arch. Toxicol. pmid:22648071
Lin F et al. Protective effect of Puerarin on β-amyloid-induced neurotoxicity in rat hippocampal neurons. 2012 Arzneimittelforschung pmid:22278629
Zhao T et al. The mechanism of 3-methoxy puerarin on decreasing the cerebral ischemia-reperfusion injury in rats. 2007 Asia Pac J Clin Nutr pmid:17392123
Chen F et al. Puerarin enhances superoxide dismutase activity and inhibits RAGE and VEGF expression in retinas of STZ-induced early diabetic rats. 2012 Asian Pac J Trop Med pmid:23146804
Ma JQ et al. Puerarin attenuates carbon tetrachloride-induced liver oxidative stress and hyperlipidaemia in mouse by JNK/c-Jun/CYP7A1 pathway. 2014 Basic Clin. Pharmacol. Toxicol. pmid:24698568
Tang XL et al. Dynamic oxidative stress and DNA damage induced by oestrogen deficiency and protective effects of puerarin and 17β-oestradiol in ovariectomized rats. 2012 Basic Clin. Pharmacol. Toxicol. pmid:22333267
Yang X et al. Puerarin inhibits C-reactive protein expression via suppression of nuclear factor kappaB activation in lipopolysaccharide-induced peripheral blood mononuclear cells of patients with stable angina pectoris. 2010 Basic Clin. Pharmacol. Toxicol. pmid:20346059
Wang B et al. [Clinical analysis of 5 cases with acute intravascular hemolysis caused by puerarin]. 2004 Beijing Da Xue Xue Bao pmid:14970887
Li B and Yu S [Effect of puerarin on the bone metabolism in vitro]. 2003 Beijing Da Xue Xue Bao pmid:12920814
Cheng W et al. Puerarin improves cardiac function through regulation of energy metabolism in Streptozotocin-Nicotinamide induced diabetic mice after myocardial infarction. 2015 Biochem. Biophys. Res. Commun. pmid:26079885
Liu B et al. Puerarin prevents cardiac hypertrophy induced by pressure overload through activation of autophagy. 2015 Biochem. Biophys. Res. Commun. pmid:26188094
Noh BK et al. Restoration of autophagy by puerarin in ethanol-treated hepatocytes via the activation of AMP-activated protein kinase. 2011 Biochem. Biophys. Res. Commun. pmid:21964292
Lin YJ et al. Puerariae radix isoflavones and their metabolites inhibit growth and induce apoptosis in breast cancer cells. 2009 Biochem. Biophys. Res. Commun. pmid:19013426
Lee JH et al. The suppressive effect of puerarin on atopic dermatitis-like skin lesions through regulation of inflammatory mediators in vitro and in vivo. 2018 Biochem. Biophys. Res. Commun. pmid:29524423
Liu B et al. Puerarin protects against heart failure induced by pressure overload through mitigation of ferroptosis. 2018 Biochem. Biophys. Res. Commun. pmid:29427658
Mercer LD et al. Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures. 2005 Biochem. Pharmacol. pmid:15627486
Vera JC et al. Direct inhibition of the hexose transporter GLUT1 by tyrosine kinase inhibitors. 2001 Biochemistry pmid:11170395
Deng Y et al. ERK5/KLF2 activation is involved in the reducing effects of puerarin on monocyte adhesion to endothelial cells and atherosclerotic lesion in apolipoprotein E-deficient mice. 2018 Biochim. Biophys. Acta pmid:29723698
Huang F et al. Puerarin attenuates endothelial insulin resistance through inhibition of inflammatory response in an IKKβ/IRS-1-dependent manner. 2012 Biochimie pmid:22314193
Lee OH et al. Puerarin enhances adipocyte differentiation, adiponectin expression, and antioxidant response in 3T3-L1 cells. 2010 Nov-Dec Biofactors pmid:20806284
Wang ZK et al. Alleviation of Lead-Induced Apoptosis by Puerarin via Inhibiting Mitochondrial Permeability Transition Pore Opening in Primary Cultures of Rat Proximal Tubular Cells. 2016 Biol Trace Elem Res pmid:27116952
Mo SF et al. Hypouricemic action of selected flavonoids in mice: structure-activity relationships. 2007 Biol. Pharm. Bull. pmid:17666819
Zhang Y et al. Puerarin Prevents LPS-Induced Osteoclast Formation and Bone Loss via Inhibition of Akt Activation. 2016 Biol. Pharm. Bull. pmid:27904045
Kim DH et al. Metabolism of puerarin and daidzin by human intestinal bacteria and their relation to in vitro cytotoxicity. 1998 Biol. Pharm. Bull. pmid:9657051
Yao WJ et al. Effect of poly(amidoamine) dendrimers on corneal penetration of puerarin. 2010 Biol. Pharm. Bull. pmid:20686234
Li B et al. Puerarin enhances bone mass by promoting osteoblastogenesis and slightly lowering bone marrow adiposity in ovariectomized rats. 2014 Biol. Pharm. Bull. pmid:25590084
Park EK et al. Intestinal bacteria activate estrogenic effect of main constituents puerarin and daidzin of Pueraria thunbergiana. 2006 Biol. Pharm. Bull. pmid:17142977
Zhang S et al. Puerarin induces angiogenesis in myocardium of rat with myocardial infarction. 2006 Biol. Pharm. Bull. pmid:16651724
Jin JS et al. Biotransformation of C-glucosylisoflavone puerarin to estrogenic (3S)-equol in co-culture of two human intestinal bacteria. 2008 Biol. Pharm. Bull. pmid:18670101
Nakamura K et al. Enzymatic cleavage of the C-glucosidic bond of puerarin by three proteins, Mn(2+), and oxidized form of nicotinamide adenine dinucleotide. 2013 Biol. Pharm. Bull. pmid:23328408
Zhao LX et al. The permeability of puerarin loaded poly(butylcyanoacrylate) nanoparticles coated with polysorbate 80 on the blood-brain barrier and its protective effect against cerebral ischemia/reperfusion injury. 2013 Biol. Pharm. Bull. pmid:23902970
Yasuda T et al. Urinary and biliary metabolites of puerarin in rats. 1995 Biol. Pharm. Bull. pmid:7742802
Yue PF et al. The study to reduce the hemolysis side effect of puerarin by a submicron emulsion delivery system. 2008 Biol. Pharm. Bull. pmid:18175940
Choo MK et al. Antithrombotic and antiallergic activities of daidzein, a metabolite of puerarin and daidzin produced by human intestinal microflora. 2002 Biol. Pharm. Bull. pmid:12392089
Bao L et al. The anti-atherosclerotic effects of puerarin on induced-atherosclerosis in rabbits. 2015 Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub pmid:24510110
Ji Y et al. Anticerebral Ischemia-Reperfusion Injury Activity of Synthesized Puerarin Derivatives. 2016 Biomed Res Int pmid:27807543
Zhang H et al. Puerarin Inhibits oxLDL-Induced Macrophage Activation and Foam Cell Formation in Human THP1 Macrophage. 2015 Biomed Res Int pmid:26576421
Cui S et al. Study on the bioavailability of puerarin from Pueraria lobata isoflavone self-microemulsifying drug-delivery systems and tablets in rabbits by liquid chromatography-mass spectrometry. 2005 Biomed. Chromatogr. pmid:15627278
Li C et al. Non-aqueous capillary electrophoresis for simultaneous separation and determination of three major active components in traditional medicinal preparations. 2005 Biomed. Chromatogr. pmid:15627280
Sun H et al. Simultaneous determination of epalrestat and puerarin in rat plasma by UHPLC-MS/MS: Application to their pharmacokinetic interaction study. 2017 Biomed. Chromatogr. pmid:27650591
Yan B et al. Determination of puerarin in rat cortex by high-performance liquid chromatography after intravenous administration of Puerariae flavonoids. 2006 Biomed. Chromatogr. pmid:16078309
Prasain JK et al. Pharmacokinetic study of puerarin in rat serum by liquid chromatography tandem mass spectrometry. 2007 Biomed. Chromatogr. pmid:17221935
Zhu S et al. Preparation of a super-long two column chromatography system and its application in separating glycosylated puerarin. 2009 Biomed. Chromatogr. pmid:19603387
Krittanai S et al. Development of a colloidal gold nanoparticle-based immunochromatographic strip for the one-step detection of miroestrol and puerarin. 2018 Biomed. Chromatogr. pmid:29972702
Li Y et al. Comparative pharmacokinetics of prim-O-glucosylcimifugin and cimifugin by liquid chromatography-mass spectrometry after oral administration of Radix Saposhnikoviae extract, cimifugin monomer solution and prim-O-glucosylcimifugin monomer solution to rats. 2012 Biomed. Chromatogr. pmid:22253022
Wen Y et al. Simultaneous determination of lidamycin enediyne chromophore (LDC) and its aromatized derivative (LDCA) using puerarin as internal standard in rat plasma by LC-MS/MS. 2012 Biomed. Chromatogr. pmid:21830226
Liu J et al. An improved LC-MS/MS method for simultaneous determination of 1,5-dicaffeoylquinic acid and its active metabolites in human plasma and its application to a pharmacokinetic study in patients. 2010 Biomed. Chromatogr. pmid:20058327
Yu Z et al. HPLC determination of safflor yellow A and three active isoflavones from TCM Naodesheng in rat plasma and tissues and its application to pharmacokinetic studies. 2007 Biomed. Chromatogr. pmid:17385809
Wang Y et al. Simultaneous determination of four components in Baige capsule by HPLC: application to pharmacokinetics and tissue distribution of normal and middle cerebral artery occlusion rats. 2014 Biomed. Chromatogr. pmid:24122939
Xu XH et al. Inhibition of excitatory amino acid efflux contributes to protective effects of puerarin against cerebral ischemia in rats. 2007 Biomed. Environ. Sci. pmid:17948770
Dong Z et al. RGD modified and PEGylated lipid nanoparticles loaded with puerarin: Formulation, characterization and protective effects on acute myocardial ischemia model. 2017 Biomed. Pharmacother. pmid:28236703
Shiying L et al. Puerarin promoted proliferation and differentiation of dopamine-producing cells in Parkinson's animal models. 2018 Biomed. Pharmacother. pmid:30119192
Deng HF et al. Puerarin prevents vascular endothelial injury through suppression of NF-κB activation in LPS-challenged human umbilical vein endothelial cells. 2018 Biomed. Pharmacother. pmid:29775893
Liu Q et al. Puerarin improves methotrexate-induced renal damage by up-regulating renal expression of Oat1 and Oat3 in vivo and in vitro. 2018 Biomed. Pharmacother. pmid:29710508
Liu X et al. Puerarin suppresses LPS-induced breast cancer cell migration, invasion and adhesion by blockage NF-κB and Erk pathway. 2017 Biomed. Pharmacother. pmid:28558356